Objective: To evaluate left-sided and right-sided heart echocardiographic results after restrictive mitral annuloplasty in chronic ischemic mitral regurgitation.
Although there is no evidence from randomized trials, observational studies have shown that treatment of chronic ischemic mitral regurgitation (CIMR) by mitral valve repair and coronary artery bypass grafting (CABG) leads to a better outcome than CABG alone. 1 It has been demonstrated that restrictive mitral annuloplasty (RMA)þCABG has a positive effect on short-term follow-up reverse remodeling. 2 Debate continues, however, with regard to survival benefits, 3 which is also reflected in the latest American College of Cardiology/American Heart Association Guidelines. 4 Nevertheless, despite that the results of mitral repair for CIMR have improved over the last 20 years, ongoing dissatisfaction with outcomes and recurrences have yielded many different approaches to CIMR. 5 Accordingly, the long-term efficacy of RMA is still unclear, and recurrence of CIMR has been Abbreviations and Acronyms CABG ¼ coronary artery bypass grafting CD ¼ coaptation depth CIMR ¼ chronic ischemic mitral regurgitation LAD ¼ left atrial diameter LVEDD ¼ left ventricular end-diastolic diameter LVEF ¼ left ventricular ejection fraction LVESD ¼ left ventricular end-systolic diameter LVMi ¼ left ventricular mass index mean Dp ¼ transmitral mean gradient NYHA ¼ New York Heart Association PAPs ¼ systolic pulmonary arterial pressure RMA ¼ restrictive mitral annuloplasty RVEF ¼ right ventricular ejection fraction TAPSE ¼ tricuspid annular plane systolic excursion TI ¼ tricuspid insufficiency predominantly related to progressive left ventricular dilation and responsible for recurrent congestive heart failure and follow-up morbidity and mortality. 6 Few literature data exist regarding mid-to long-term echocardiographic results after RMA. 7 Finally, despite the supposed beneficial effects of RMA in terms of congestive heart failure and left ventricular reverse remodeling, little is known about the fate of the right ventricle after RMA, although a recent study has proven RMA to act as a native mitral stenosis. 8 This study evaluates the midterm clinical and echocardiographic results of a consecutive series of patients undergoing RMAþCABG for CIMR, focusing on left and right ventricular function and remodeling, with subgroup analysis in patients with tricuspid surgery.
MATERIALS AND METHODS Patients and Surgery
Between August 2004 and September 2007, 66 consecutive patients who were admitted with CIMR and underwent RMA þ CABG with at least 6 months of postoperative follow-up were enrolled. Institutional review board approved conducting this study and waived the need for individual consent. CIMR was defined as mitral regurgitation occurring more than 1 week after myocardial infarction with 1 or more left ventricular segmental wall motion abnormalities, significant coronary disease in the territory supplying the wall motion abnormality, and structurally normal mitral valve leaflets and chordae tendinae. 5 Therefore, patients with organic mitral disease (eg, myxomatous, rheumatic) were excluded from the study. All patients had coronary artery disease and CIMR grade 3þor 4þat preoperative echocardiography (semiquantitatively from color-flow Doppler). Patients demonstrating 2þ CIMR underwent further provocative intraoperative testing (rapid infusion of volume until the wedge pressure reached 16 to 18 mm/Hg or phenylenephrine administration until mean arterial pressure reached 100 mm/Hg) 9 and were enrolled whenever 3þto 4þmitral regurgitation was shown.
CIMR was always caused by post-infarction restrictive systolic leaflet motion (Carpentier type IIIb) (Table 1) , severe annular dilation resulting from ischemic dilated cardiomyopathy (Carpentier type I), or a combination of both (Carpentier type I þ IIIb) ( Table 1) . Patients with concomitant surgery (eg, surgical ventricular restoration, papillary sling, aortic valve surgery), apart from tricuspid annuloplasty, were excluded from the study. Accordingly, tricuspid regurgitation 2þor greater or tricuspid regurgitation less than 2þin the presence of dilated tricuspid annulus exceeding 21 mm/m 2 indexed to body surface area at transthoracic echocardiography indicated concomitant tricuspid annuloplasty. 10 All patients had symptoms of heart failure, and the majority presented New York Heart Association (NYHA) class III or IV (Table 1) . Mean logistic European System for Cardiac Operative Risk Evaluation was 10.8 AE 3.1. The diagnosis of chronic obstructive pulmonary disease was based on the Summit database definition: Each patient required treatment for chronic pulmonary compromise or had a forced expiratory volume in 1 second less than 75% of predicted value or a forced expiratory volume in 1 second to forced expiratory vital capacity less than 0.7 at preoperative spirometry. Baseline characteristics are presented in Table 1 .
Surgery was performed by the same surgeon (A.R.) in all cases through a median sternotomy. The ascending aorta was always cannulated, and venous return was always accomplished through a double caval cannulation. All patients underwent left internal thoracic artery to the left anterior descending grafting. The radial artery was used in 18 patients and always harvested as a pedicle with an ultrasonic scalpel (Ethicon Endo-Surgery, Cincinnati, Ohio). Saphenous veins were always harvested from the best side, as detected by preoperative echo-Doppler scanning. All grafts underwent intraoperative transit-time analysis, and unsatisfactory results always led to redo CABG. 11 The mitral valve was exposed through a longitudinal atriotomy along the Waterston's groove in all patients. Ring size (Carpentier-Edwards Physio ring; Edwards Lifesciences, Irvine, Calif or Carpentier-McCarthy-Adams ring, Edwards Lifesciences) was determined after careful measurement of the height of the anterior leaflet and intertrigonal distance, and then downsizing by 2 sizes (ie, size 26 when measuring 30). Complete symmetric rings (Carpentier-Edwards Physio ring) were preferred when CIMR was predominantly caused by annular dilation (Carpentier type I), and complete asymmetric rings (Carpentier-McCarthy-Adams ring) were preferred when inferior or posterolateral infarction caused restrictive systolic leaflet motion (Carpentier type IIIb). Tricuspid annuloplasty was always accomplished with a Carpentier Edwards MC3 ring (Edwards Lifesciences). By using the Carpentier's measurement technique, the appropriate ring size was selected on the basis of the length of the attachments of the tricuspid septal leaflet and the surface area of the anterior leaflet, and then downsized by at least 1 measure. Ring implantation was performed by placing 8 to 10 mattress sutures through the tricuspid annulus around the orifice, avoiding the area of atrioventricular conduction tissue. Cardiopulmonary bypass was standardized: a Dideco (Mirandola, Modena, Italy) tubing set, which included a 40-mm filter, Stockert roller pump (Stockert Instrumente, Munich, Germany), and hollow fiber membrane oxygenator (Dideco D903 Avant, Mirandola). Myocardial protection was always achieved with intermittent antegrade and retrograde hyperkalemic blood cardioplegia.
Anticoagulation Protocol
It was institutional policy to start 4000 IU low molecular weight heparin (nadroparin) 2 times per day 8 hours after surgery. Warfarin therapy was started on the second postoperative day, targeted to an international normalized ratio between 2.0 and 3.0 in patients with sinus rhythm and between 2.5 and 3.5 in patients with atrial fibrillation, until the third postoperative month. Oral antiplatelet therapy (acetylsalicylic acid 150 mg/d) was started thereafter.
Echocardiography
Echocardiography was always accomplished by the same 3 cardiologists, using a VIVID 7 Pro ultrasound machine (GE Technologies, Milwaukee, Wis). All patients underwent preoperative transthoracic and transesophageal echocardiography. Transthoracic echocardiographic evaluation consisted of standard echocardiography examination, including grading of severity of CIMR (semiquantitatively from color-flow Doppler), left atrial diameter (LAD), left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD), left ventricular ejection fraction (LVEF), left ventricular mass index (LVMi), coaptation depth (CD), transmitral mean gradient (mean Dp), systolic pulmonary arterial pressure (PAPs), tricuspid annular plane systolic excursion (TAPSE), and tricuspid insufficiency (TI) grading. Apical 4-chamber view was accomplished to measure severity of CIMR, LAD, LVEF (Simpson's method), CD, and transmitral mean Dp. Parasternal long-axis view was used to measure LVEDD and LVESD by M-mode.
The severity of CIMR was determined by the ratio of maximum color Doppler regurgitant jet area to left atrial area. CIMR grade was estimated as trivial, mild, moderate, or severe on the basis of ratios of 0% to 10%, 10% to 20%, 20% to 40%, and greater than 40%, respectively. 10 Mean preoperative CIMR was 3.4 AE 0.6 (range 2þto 4þ). Indexed left ventricular mass was calculated according to Devereux's formula. 12 TI was evaluated using the apical 4-chamber view. TI was graded as trace (1þ), mild (2þ), moderate (3þ), or severe (4þ) when the jet area occupied less than 10%, 10% to 20%, 20% to 33%, or more than 33% of the right atrial area, respectively. 10 Mean preoperative TI was 2.0 AE 0.6 (range 2þto 4þ). TAPSE was measured by 2-dimensional echocardiography from the apical 4-chamber view at the right ventricular free wall level, as described by Kaul and colleagues. 13 Finally, right ventricular ejection fraction (RVEF) was calculated after TAPSE analysis from an apical 4-chamber view, according to Kaul and colleagues 13 and Ueti and colleagues. 14 Mitral valve repair was considered successful at intraoperative transesophageal echocardiography if there was no residual mitral regurgitation after cardiopulmonary bypass discontinuation with an achieved adequate preload (central venous pressure 10-15 mm Hg). All patients also had intraoperative assessment of left ventricular function. Postoperatively, transthoracic echocardiography was re-peated before discharge, at early follow-up (6 months), and at the end of follow-up. Mean follow-up was 22.3 AE 14.8 months (range 6-55 months). Recurrence of CIMR was defined as 2þ/4þ grade or greater mitral regurgitation at any time postoperatively at semiquantitative color-flow Doppler analysis and recorded in the institutional database. Follow-up was closed on April 1, 2008, and was 100% completed.
Clinical Assessment
NYHA was determined preoperatively, up to 5 days before surgery, at discharge, at 6 months, and at the end of follow-up in the outpatient clinic. As a surrogate outcome of heart failure, need and dose of furosemide were assessed at the same time points. Deaths and episodes of acute congestive heart failure, hospital readmission, and redo mitral/coronary surgery during the follow-up were recorded.
Statistical Analysis
Statistical analysis was performed by the Statistical Program for the Social Sciences for Windows, version 13.0 (SPSS Inc, Chicago, Ill). Continuous variables are presented as mean AE standard deviation, and categoric variables are presented as absolute numbers or percentages. Normally distributed continuous variables were compared using the unpaired t test, whereas the Mann-Whitney U test was used for not normally distributed variables. Categoric variables were analyzed using the chi-square or Fisher's exact test. Comparison between and within groups was made using 2-way analysis of variance for repeated measures. Follow-up survival and freedom from congestive heart failure, hospital readmission, and redo surgery were determined with Kaplan-Meier life table analysis. Log-rank test was performed to ascertain differences between patients with and without CIMR recurrence.
RESULTS

Hospital Outcome
Preoperative and intraoperative data are reported in Table  1 . Two patients demonstrated persistent intraoperative 1 to 2þ CIMR despite 2-size undersizing and underwent mitral valve replacement after reestablishment of cardiopulmonary bypass. These 2 patients were excluded from the study because of the different surgical therapy. Successful mitral valve repair was achieved in all the remaining 64 patients, regardless of the degree of leaflet tethering. Therefore, only 64 patients were enrolled and followed up. Mean mitral ring size was 25 (Figure 1, A) . Both patients died within the 6-month follow-up period; therefore, 58 patients surviving beyond the sixth month were completely followed up with echocardiography.
Eight patients had congestive heart failure during followup, 10 patients required hospitalization because of cardiac causes, and 2 patients underwent re-revascularization, giving a 21.3 AE 15.6 months actuarial freedom from congestive heart failure of 71.6% AE 10.5% (Figure 1, B (Figure 1, D) . Recurrence of CIMR 2þ or greater at echocardiographic follow-up developed in 16 of 60 patients who were discharged from the hospital (26.6%). Of these patients, 2 died during early follow-up, as already reported; therefore, 14 (24.1%) of 58 patients surviving more than 6 months had CIMR 2þ or greater, resulting in 22.5 AE 15.8 months of actuarial freedom from CIMR (58.2% AE 9.8%) ( Figure 2 , A). Patients with recurrence of CIMR did not show differences in the type of implanted ring ( However, when patients with CIMR were compared with those without CIMR, a significantly lower freedom from CHF (log-rank P ¼ .0001; Figure 2 , B), hospitalization (P ¼ .0001; Figure 2 , C), and reintervention (P ¼ .034; Figure 2 , D) was demonstrated. When functional status was considered, despite the fact that both groups of patients, with or without recurrent CIMR, improved their NYHA, those without CIMR during follow-up showed significantly better recovery of NYHA and a significantly lower need for diuretics ( Table 2) . Accordingly, recurrent CIMR induced progressive increase of daily furosemide during the follow-up (Table 2) . Finally, when patients with preoperative LVEDD 70 mm or greater were analyzed, low follow-up freedom from CHF and hospitalization was found (both 21.2% AE 17.4%) ( Figure 3, A and B) . Moreover, compared with patients with preoperative LVEDD less than 70 mm, a significantly lower freedom from CHF (P ¼ .001; Figure 3 , A) and hospitalization (P ¼ .006; Figure 3 , B), together with a higher recurrence of CIMR (P ¼ .002; Figure 3 , C), was shown.
Echocardiographic Results
A different pattern of left ventricular results was found in patients with recurrent CIMR and patients without CIMR. In particular, patients with CIMR correlated with absence of reverse remodeling of LAD, LVEDD, LVESD, and LVMi (Table 3) . Accordingly, LVEF did not improve during follow-up (Table 3 ). However, after a significant improvement of mitral CD at discharge, CD increased parallel to the worsening of CIMR, whereas transmitral mean Dp diminished ( Table 3) .
On the other hand, patients without CIMR showed significant reverse remodeling of LVEDD, LVESD, and LVMi together with improvement of their LVEF and persistently shortened CD from discharge to the end of follow-up. These same patients also showed a higher mean Dp (compared with patients with recurrent CIMR), which remained stable during follow-up and is potentially responsible for the ab-sence of LAD reverse remodeling (Table 3 ). However, apart from preoperative LVMi, no significant differences were found in baseline clinical and echocardiographic characteristics between patients with recurrent CIMR and patients without CIMR (Table 4) .
When right ventricular echocardiographic results were analyzed, despite the fact that TI improved both in patients with and without recurrent CIMR, neither group showed any right-sided heart amelioration in terms of PAPs, RVEF, and TAPSE ( Table 5 ). In particular, patients with recurrent CIMR evidenced a slight progressive worsening of PAPs and a slight deterioration of RVEF (although not statistically significant), without improvement of TAPSE during the follow-up. On the other hand, although patients without CIMR did not show any improvement in PAPs, RVEF, and TAPSE during follow-up, despite the postoperative reduction of TI grade, they did not have deterioration of PAPs, RVEF, and TAPSE (Table 5) .
Stratification According to Tricuspid Surgery
Subgroup analysis in patients who did not undergo tricuspid surgery at the time of RMA demonstrated significant differences in right-sided heart echocardiographic parameters during follow-up. In particular, patients developing recurrence of CIMR demonstrated a progressive worsening of TI grade (after an initial early amelioration), with depressed RVEF and TAPSE and high PAPs, whereas patients without CIMR showed a progressive improvement of TI grade, PAPs, RVEF, and TAPSE (Table 6 ). Obviously, patients with recurrent CIMR demonstrated progressive worsening of NYHA with a greater need for daily diuretics, whereas patients without CIMR progressively improved their NYHA and decreased their daily diuretic dose ( Table 6) .
On the other hand, patients undergoing tricuspid annuloplasty did not demonstrate any improvement of PAPs, RVEF, and TAPSE during follow-up, regardless of the recurrence of CIMR. However, in those without CIMR, the absence of recurrent CIMR together with the effects of the tricuspid annuloplasty improved TI grade during follow-up (Table 7) , with a significant amelioration of NYHA and a significant reduction of the daily diuretic dose, compared with patients with recurrent CIMR (Table 7) .
DISCUSSION
CIMR is considered to be a common cause of postmyocardial infarction congestive heart failure and has been considered one of the few targets for therapeutic opportunities in patients with heart failure. 5 According to the complex and different pathogenetic mechanisms underlying such disease, several different surgical techniques have been developed for CIMR, from RMA to mitral valve replacement, chordal cutting, papillary imbrication, sling, and repositioning to percutaneous annuloplasty and so on, the majority of which are still considered experimental. 2, 5, 7 Because of the safety and reproducibility of RMA, our operative mortality (6%) is in line with other studies and well below the logistic European System for Cardiac Operative Risk Evaluation for this group. 7 Moreover, our favorable overall midterm outcome with a 2-year actuarial survival of 96% is better than that reported by Grossi and colleagues 15 but comparable to that reported by others. 16, 17 On the other hand, it is well known that patients with CIMR have a worse natural history than patients with ischemic heart disease without CIMR. A study of 11,748 patients who underwent cardiac catheterization revealed that severe CIMR was associated with a 1-year mortality of 40%, moderate CIMR of 17%, and mild CIMR of 10%. 18 The SAVE study demonstrated that mild chronic CIMR increases the risk of cardiovascular mortality (29% vs 12%) and heart failure (24% vs 16%) than patients without CIMR at a mean of 3.5 years after myocardial infarction. Adjustment for differences in baseline characteristics revealed that mild-to-moderate CIMR strongly predicted midterm mortality. 19 Therefore, it is not surprising that patients with recurrent CIMR showed lower survival, freedom from CHF, hospitalization, and reintervention, together with a progressive worsening of their NYHA and need for diuretics, when compared with patients without recurrences. Our findings correlated with those of De Bonis and colleagues, 20 showing a significantly worse NYHA when CIMR recurs, and of Gelsomino and colleagues, 21 who also found higher NYHA class and reoperation rate in patients with failed RMA.
RMA has been successfully used by Bolling and colleagues 22 for more than a decade. Despite the enthusiasm for the low perioperative mortality rates and the positive effects on survival, CHF, and functional NYHA class, several studies have clearly addressed that RMA is affected by a variable recurrence rate. 2, 5, 7, [15] [16] [17] [18] [19] [20] [21] A recent article examined 585 patients undergoing RMA over a 17-year period: In 28% of patients, moderate or more mitral regurgitation developed 6 months postoperatively, an incidence that is similar to that described by other investigators. 23 Although recurrence tends to occur early postoperatively with relatively low recurrence rates thereafter, 24 progressive ventricular dilation and ongoing cardiomyopathy seem to be responsible for recurrence rate during follow-up. 7, 21, [24] [25] [26] Preoperative highly remodeled left ventricles are considered to have a poor success rate at follow-up: Braun and colleagues 7 showed preoperative LVEDD greater than 65 mm to correlate with higher recurrence of CIMR with worse survival and NYHA class. Gelsomino and colleagues 21 found large ventricular volumes and high sphericity index to be predictive of an absence of reverse remodeling and a higher recurrence rate. Roshanali and colleagues 25 showed preoperative interpapillary muscle distance to be related to recurrent CIMR during follow-up. Calafiore and colleagues 26 demonstrated high preoperative CD more than 10 mm to correlate with recurrence. We found 24% CIMR recurrence, with a slightly lower freedom from CIMR during follow-up compared with previous studies, 2,7,21,23 possibly because of the slightly worse profile of preoperative echocardiographic parameters of our population (LVEDD 64-67 mm and CD>13 mm in almost all patients). According to previous series, 2,7,21,24-26 our patients demonstrating recurrent CIMR showed slightly higher preoperative LVEDD and LVESD, confirming that a higher degree of preoperative ventricular remodeling may correlate with RMA failure. Furthermore, according to Braun and colleagues, 7 successful RMA cured CIMR, also correlating with reverse remodeling of LVEDD, LVESD, and LVMi in our population. However, whether the recurrence of CIMR anticipates the absence of reverse remodeling of LVEDD, LVESD, and LVMi, or the absence of reverse remodeling of LVEDD, LVESD, and LVMi determines the recurrence of CIMR should be the topic of future studies. Moreover, we found a different pattern of echocardiographic CD and mean transmitral Dp in patients with or without recurrence. In particular, patients without CIMR showed lower CD at discharge, parallel to high mean Dp. Both indexes remained stable during follow-up. On the other hand, patients in whom RMA failed demonstrated deeper CD at discharge with a low mean transmitral Dp, which worsened further during followup. These data confirm CD as a reliable index of recurrent CIMR. 25, 26 Moreover, subgroup analysis in patients with preoperative severe dilation of the left ventricle (LVEDD >70 mm) confirmed that these patients, as previously described, 7 had a worse prognosis in terms of CHF. If general agreement exists on the beneficial effects of RMA on left ventricular remodeling, little is known of the fate of the right chambers. A recent study showed the potential of RMA to induce iatrogenic mitral stenosis. 8 Functional TI is often associated with mitral valve disease and thought to be caused by dilatation of the tricuspid annulus and tethering of the tricuspid leaflets resulting from right ventricular dilatation. 27 Functional tricuspid regurgitation is now en-countered regularly in patients with severe left ventricular dysfunction who undergo cardiac operations. 7, 8, [28] [29] [30] [31] [32] Tricuspid annuloplasty represents the common surgical strategy, although the rate of recurrent regurgitation remains high. 28, 29 Moreover, most of the data available on the outcome of functional tricuspid regurgitation after mitral surgery come from series of patients affected by degenerative 28 or rheumatic mitral disease, 30 whereas only few reports deal with regurgitation of the tricuspid valve in the context of dilated cardiomyopathy. 8, 29 Our population substantially showed little impact of RMA on right-sided heart evolution. Obviously, when CIMR recurred, the persistence of the left-sided disease did not ameliorate TI, PAPs, RVEF, and TAPSE, regardless of whether patients underwent tricuspid annuloplasty at the time of RMA. It was recently demonstrated that the progression or recurrence of significant TI occurred among patients who did not show signs of reverse left ventricular remodeling after magnetic resonance angiography for dilated cardiomyopathy. 27 Di Mauro and colleagues 31 demonstrated right ventricular dysfunction in patients undergoing RMA, which correlated with worsening NYHA and reduced survival. Accordingly, our patients with failed RMA not only demonstrated the absence of leftheart reverse remodeling but also failed to improve their TI, PAPs, RVEF, and TAPSE. Furthermore, they had to increase their daily dose of diuretics and worsened their NYHA whenever CIMR recurred in patients without previous tricuspid surgery. On the other hand, patients without CIMR showed a completely different evolution of the right chambers, based on the need for tricuspid surgery at the time of RMA. Patients without CIMR who did not undergo tricuspid annuloplasty at the time of RMA demonstrated progressive amelioration of TI grade, along with PAPs, RVEF, and TAPSE, whereas patients undergoing tricuspid surgery at the time of RMA did not show improved PAPs, RVEF, and TAPSE despite good functional results of the RMA itself. Dreyfus and colleagues 32 clearly demonstrated that tricuspid annular dilatation is an ongoing process, advocating that any patient with substantial annular dilatation should undergo repair regardless of the TI grade. Matsuyama and associates 33 reported that 16% of the patients who underwent mitral valve surgery without concomitant tricuspid valve surgery developed 3þto 4þ TI at an 8-year follow-up.
CONCLUSIONS
Our results show that patients undergoing tricuspid surgery have a worse echocardiographic profile compared with those not undergoing tricuspid annuloplasty, being patients with an already compromised right ventricle at the time of surgery (low TAPSE and RVEF, high PAPs). These patients therefore have a reduced possibility of reverse remodeling of the right side of the heart. It is well known that ventricular dilation or severe tethering before surgery anticipates TI recurrence despite annuloplasty. 34 Moreover, it can be speculated that in this subset of patients, the higher mean transmitral Dp (demonstrated in patients without CIMR during follow-up) may act as a ''iatrogenic'' mild mitral stenosis, preserving the left ventricle from progressive dilation but further overloading an already diseased right ventricle. 8 The absence of left ventricular remodeling in patients with a severely dilated left ventricle identifies a more advanced ''left-sided'' stage of the disease (with poor outcome after isolated RMA), where the left ventricle itself needs to be addressed. 7 Accordingly, it can be hypothesized that the need for tricuspid annuloplasty at the time of RMA identifies a more advanced ''right-sided'' stage of cardiomyopathy, where tricuspid annuloplasty itself is not sufficient to improve the right side of the heart, further overloaded by an increased pulmonary pressure induced by RMA itself. However, the absence of CIMR together with the effect of tricuspid surgery in this highly diseased category of patients avoids volume overload on an already compromised right ventricle, leading at least to a better NYHA class (and lower diuretic need) compared with patients with CIMR recurrence. Therefore, only patients undergoing mitral surgery without functional tricuspid disease may benefit from RMA alone. However, further studies addressing right heart evolution after RMA in patients with ischemic dilated cardiomyopathy are needed to clarify such a topic.
